Skip to main content
. 2021 Apr 26;29(2):201–211. doi: 10.5606/tgkdc.dergisi.2021.19956

Table 2. Risk factors affecting mortality in the first 90 days.

  Mortality negative Mortality positive p
  n % n %  
Age (year)         0.475
<65 31 88.6 4 100  
>65 4 11.4 0 0  
Sex         0.732
Male 34 971 4 100  
Female 1 2.9 0 0  
Side         0.609
Left 12 34.3 2 50  
Right 23 65.7 2 50  
Charlson Comorbidity Index         0.318
2 20 57.1 1 25  
>2 15 42.9 3 75  
Induction treatment         0.323
CHT 7 20 0 0  
CHT-RT 28 80 4 100  
Induction treatment chemotherapy cycles         0.556
2 10 28.6 0 0  
4-6 25 71.4 4 100  
Radiotherapy dose         0.279
<60 Gy 18 64.3 1 25  
>60 Gy 10 35.7 3 75  
yTNM         0.179
I 16 45.7 0 0  
II 18 51.4 4 100  
III 1 2.9 0 0  
Resection         0.099
Lobectomy 25 71.4 1 25  
Pneumonectomy 10 28.6 3 75  
Histopathology         0.792
Adenocarcinoma 11 31.4 1 25  
SqCC 24 68.6 3 75  
Adjuvant         0.556
Negative 25 71.4 4 100  
Positive 10 28.6 0 0  
CHT: Chemotherapy; RT: Radiotherapy; Gy: Gray; SqCC: Squamous Cell Carcinoma; yTNM: Tumor, nodes, and metastases after induction therapy.